Evidence map›Paper›PMID 39759522›Full record

ArticleFrontiers in immunology2024

Spatially-resolved analyses of muscle invasive bladder cancer microenvironment unveil a distinct fibroblast cluster associated with prognosis.

Chao Feng, Yaobang Wang, Wuyue Song, Tao Liu, Han Mo, Hui Liu, Shulin Wu, Zezu Qin, Zhenxing Wang, Yuting Tao and 5 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Histopathological Basis of Peritumoral Enhancement in Muscle-invasive Bladder Cancer.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Chao Feng *Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yaobang Wang *Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
Wuyue Song *Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Tao LiuInstitute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Han MoInstitute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Hui LiuInstitute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Shulin WuInstitute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zezu QinInstitute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhenxing WangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
Yuting TaoCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
Liangyu HeInstitute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Shaomei TangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
Yuanliang XieCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
Qiuyan WangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
Tianyu LiInstitute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Muscle-invasive bladder cancer (MIBC) is a prevalent cancer characterized by molecular and clinical heterogeneity. Assessing the spatial heterogeneity of the MIBC microenvironment is crucial to understand its clinical significance. Methods: In this study, we used imaging mass cytometry (IMC) to assess the spatial heterogeneity of MIBC microenvironment across 185 regions of interest in 40 tissue samples. We focused on three primary parameters: tumor (T), leading-edge (L), and nontumor (N). Cell gating was performed using the Cytobank platform. We calculated the Euclidean distances between cells to determine cellular interactions and performed single-cell RNA sequencing (scRNA-seq) to explore the molecular characteristics and mechanisms underlying specific fibroblast (FB) clusters. scRNA-seq combined with spatial transcriptomics (ST) facilitated the identification of ligand-receptor (L-R) pairs that mediate interactions between specific FB clusters and endothelial cells. Machine learning algorithms were used to construct a prognostic gene signature. Results: The microenvironments in the N, L, and T regions of MIBC exhibited spatial heterogeneity and regional diversity in their components. A distinct FB cluster located in the L region-identified as S3-is strongly associated with poor prognosis. IMC analyses demonstrated a close spatial association between S3 and endothelial cells, with S3-positive tumors exhibiting increased blood vessel density and altered vascular morphology. The expression of vascular endothelial growth factor receptor and active vascular sprouting were significant in S3-positive tumors. scRNA-seq and ST analyses indicated that the genes upregulated in S3 were associated with angiogenesis. NOTCH1-JAG2 signaling pathway was identified as a significant L-R pair specific to S3 and endothelial cell interactions. Further analysis indicated that YAP1 was a potential regulator of S3. Machine learning algorithms and Gene Set Variation Analysis were used to establish an S3-related gene signature that was associated with the poor prognosis of tumors including MIBC, mesothelioma, glioblastoma multiforme, lower-grade glioma, stomach adenocarcinoma, uveal melanoma, kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma, and lung squamous cell carcinoma. Conclusions: We assessed the spatial landscape of the MIBC microenvironment and revealed a specific FB cluster with prognostic potential. These findings offer novel insights into the spatial heterogeneity of the MIBC microenvironment and highlight its clinical significance.

Indexed as

Tumor MicroenvironmentUrinary Bladder NeoplasmsBiomarkers, TumorCancer-Associated FibroblastsFemaleFibroblastsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleNeoplasm InvasivenessPrognosisSingle-Cell AnalysisTranscriptomeBiomarkers, TumorfibroblastMIBCsingle-cell omicsspatial heterogeneitytumor microenvironment

Identifiers

PMID39759522
PMCPMC11695344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.